<DOC>
	<DOCNO>NCT01724333</DOCNO>
	<brief_summary>Assessment oral dental problem seldom routine clinical oncology , despite potential negative impact problem nutritional status , social function quality life ( QoL ) . A brief , assessment tool oral/dental health relate QoL-issues improve symptom management request . The present study conduct behalf support European Organisation Research Treatment Cancer - ( EORTC ) Quality Life Group ( QLG ) . The study represent phase IV , final step , development international , symptom specific questionnaire module , focus oral dental problem relation cancer treatment . Phase I-III stepwise development process conduct 2008 2011 , international collaboration conduct accord guideline module development set forth EORTC QLG . The result module , QLQ-OH17 , subject international field test validation study describe project description . The present version QLQ-OH17 consist 17 item conceptualize four multi-item scale ( pain/discomfort , xerostomia , eat information ) three single item relate use dentures future worry . The aim present study conduct phase IV ; international field study confirm psychometric property QLQ-OH17</brief_summary>
	<brief_title>International Validation QLQ-OH17 Oral Health</brief_title>
	<detailed_description>The EORTC guideline strictly follow also phase IV module development . Eligible patient contact local study coordinator study nurse inform study . After provide write informed consent , present follow two questionnaire self-report general symptom , specific dental oral symptom , quality life issue ; EORTC QLQ-C30 QLQ-OH17 . In addition two , short debrief interview conduct study coordinator / study nurse assessment feasibility patient ' opinion questionnaire . The case report form ( CRF ) medical demographic data complete study coordinator / study nurse patient complete part . A subset patient assessed twice , examination test - retest reliability important phase IV development process .</detailed_description>
	<mesh_term>Xerostomia</mesh_term>
	<criteria>Inclusion Criteria Patients verify cancer diagnosis basal cell carcinoma , incl . H &amp; N cancer Sufficient language ability understand complete questionnaire without assistance No obvious cognitive impairment , judge study coordinator upon inclusion Age 18 year Provision write informed consent No participation another trial study possibly interfere present study Patients diagnose basal cell carcinoma Patients include Phase IIII module development Patients terminal phase cancer Patients unable participate interview obvious cognitive impairment , psychological disturbance language problem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>EORTC QLQ-C30</keyword>
	<keyword>Oral health</keyword>
	<keyword>Quality life</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Patient report</keyword>
	<keyword>outcome</keyword>
</DOC>